Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
SUM1315MO2 Cisplatin
3.1623
Chemo
Chemotherapy
0.3176 0.14509
SUM1315MO2 Cisplatin
10.0
Chemo
Chemotherapy
0.2028 0.23776
SUM1315MO2 Doxorubicin
0.00031623
Chemo
Chemotherapy
0.9250 0.01794
SUM1315MO2 Doxorubicin
0.001
Chemo
Chemotherapy
0.9638 0.00498
SUM1315MO2 Doxorubicin
0.0031623
Chemo
Chemotherapy
0.9521 0.02241
SUM1315MO2 Doxorubicin
0.01
Chemo
Chemotherapy
0.7752 0.05037
SUM1315MO2 Doxorubicin
0.031623
Chemo
Chemotherapy
0.2699 0.20353
SUM1315MO2 Doxorubicin
0.1
Chemo
Chemotherapy
0.1337 0.20540
SUM1315MO2 Doxorubicin
0.31623
Chemo
Chemotherapy
0.1933 0.20977
SUM1315MO2 Doxorubicin
1.0
Chemo
Chemotherapy
0.1753 0.23142
SUM1315MO2 Doxorubicin
3.1623
Chemo
Chemotherapy
-0.0635 0.24619
SUM1315MO2 Taxol
0.0001
Chemo
Chemotherapy
1.0258 0.01087
SUM1315MO2 Taxol
0.00031623
Chemo
Chemotherapy
1.0435 0.01056
SUM1315MO2 Taxol
0.001
Chemo
Chemotherapy
0.8773 0.06705
SUM1315MO2 Taxol
0.0031623
Chemo
Chemotherapy
0.3379 0.27957
SUM1315MO2 Taxol
0.01
Chemo
Chemotherapy
-0.1765 0.42783
SUM1315MO2 Taxol
0.031623
Chemo
Chemotherapy
-0.1802 0.42356
SUM1315MO2 Taxol
0.1
Chemo
Chemotherapy
-0.3052 0.48467
SUM1315MO2 Taxol
0.31623
Chemo
Chemotherapy
-0.2918 0.47769
SUM1315MO2 Taxol
1.0
Chemo
Chemotherapy
-0.3258 0.46429
SUM1315MO2 Topotecan
0.0010833
Topo I
Chemotherapy
0.8689 0.01114
SUM1315MO2 Topotecan
0.0033333
Topo I
Chemotherapy
0.6181 0.06747
SUM1315MO2 Topotecan
0.01
Topo I
Chemotherapy
0.4048 0.18409
SUM1315MO2 Topotecan
0.031667
Topo I
Chemotherapy
0.2827 0.22120
SUM1315MO2 Topotecan
0.1
Topo I
Chemotherapy
0.3316 0.22251